I kliniske undersøgelser havde 97% af de responderende patienter fuld respons ved doser på ≤ 2, 4 mill.
In clinical studies, 97% of patients who responded had a complete response at doses of ≤ 2.4 MU/ kg/ day (24 μ g/ kg/ day).